Last updated: 2026-09-16 09:20:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Johnson & Johnson (JNJ) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $267,27, with a market capitalization of $641,80B and a P/E ratio of 30,61. Over the past 52 weeks, its price has ranged from $173,33 to $281,07. This page covers its latest market performance, valuation, price trends and company information.
$641,80B | |
$266,29 | |
$281,07 | |
$46,25 | |
$267,20 | |
1,24K | |
7,60M | |
30,61 | |
$281,07 | |
$173,33 | |
1,96% | |
-- |
Johnson & Johnson (JNJ) is trading at $267,27 in pre-market trading as of 2026-09-16 09:19:00, up 0,03% ($0,07) from the previous close of $267,20
Pre-market trading shows how investors are pricing JNJ before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.
Over the past seven days, Johnson & Johnson (JNJ) moved from $275,23 to $267,27, representing a decline of 2,89% ($7,96).
The stock traded between $260,68 and $277,80 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 5,46 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 87,2%
JNJ is currently trading at $267,27, placing it 87,2% of the way from its 52-week low of $173,33 to its 52-week high of $281,07. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 140800 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Johnson & Johnson (JNJ) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.